Corporate Update: Motion Entertainment Group Inc. fka Compass Biotechnologies Announces New Identity, Two New Subsidiaries an...
October 04 2016 - 3:15PM
Access Wire
SALT LAKE CITY, UT / ACCESSWIRE / October 4, 2016
/ Motion Entertainment Group Inc. fka Compass
Biotechnologies (OTC: COBI) is pleased to update shareholders
regarding the Company's significant progress with its business
growth and evolution. In the last two months, the Company has filed
a name change with the Nevada Secretary of State to Motion
Entertainment Group Inc. and subsequently a corporate action filing
with FINRA which is expected to be made effective this week.
Simultaneously, the Company has reserved the symbol "MEGA" with
FINRA.
The Company has diligently worked with its partners to complete
two new subsidiary agreements, specifically Motion Sound Holdings
Inc. and Magic Trix Inc. The binding LOI's have been executed and
the Company expects to have these definitive agreements in place
within 72 hours. The subsidiaries represent the Company's shift
towards the deployment of investments and the realization of growth
and revenue within the entertainment sector.
"This has been a busy and fruitful period for the Company. I
cannot wait to update our Shareholders about the progress that has
been made in the past 60 days alone," said Interim President,
Steven Smith. "We have been focused on initiating and realizing
real business results, and now we are in a position to publicly
announce the details."
"MEGA isn't just a symbol or name," said Smith. "It's a
reflection of what we see. There is a provenance to both the
products and the people within these subsidiaries, and immediate
returns that we expect to create. This is an exciting time."
Steven Smith, Interim President
Motion Entertainment Group Inc. fka Compass Biotechnologies
Inc.
Email: compassbiotechnologies@gmail.com
Tel: (972) 535-8931
Safe Harbor: This release includes
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 27E of the Securities Act of
1934. Statements contained in this release that are not historical
facts may be deemed to be forward-looking statements. Investors are
cautioned that forward-looking statements are inherently uncertain.
Actual performance and results may differ materially from that
projected or suggested herein due to certain risks and
uncertainties including, without limitation, ability to obtain
financing and regulatory and shareholder approval for anticipated
actions.
SOURCE: Compass Biotechnologies Inc.